IL109602A - Urethanes and ureas that induce cytokine production process for their preparation and pharmaceutical compositions containing them - Google Patents

Urethanes and ureas that induce cytokine production process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL109602A
IL109602A IL10960294A IL10960294A IL109602A IL 109602 A IL109602 A IL 109602A IL 10960294 A IL10960294 A IL 10960294A IL 10960294 A IL10960294 A IL 10960294A IL 109602 A IL109602 A IL 109602A
Authority
IL
Israel
Prior art keywords
urethanes
pharmaceutical compositions
cytokine production
ureas
preparation
Prior art date
Application number
IL10960294A
Other languages
English (en)
Other versions
IL109602A0 (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL109602A0 publication Critical patent/IL109602A0/xx
Publication of IL109602A publication Critical patent/IL109602A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL10960294A 1993-05-12 1994-05-09 Urethanes and ureas that induce cytokine production process for their preparation and pharmaceutical compositions containing them IL109602A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/063,174 US5312831A (en) 1993-05-12 1993-05-12 Urethanes and ureas that induce cytokine production

Publications (2)

Publication Number Publication Date
IL109602A0 IL109602A0 (en) 1994-08-26
IL109602A true IL109602A (en) 2000-06-01

Family

ID=22047440

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10960294A IL109602A (en) 1993-05-12 1994-05-09 Urethanes and ureas that induce cytokine production process for their preparation and pharmaceutical compositions containing them

Country Status (26)

Country Link
US (6) US5312831A (cs)
EP (1) EP0652228B1 (cs)
JP (1) JP3583469B2 (cs)
KR (1) KR100296543B1 (cs)
CN (1) CN1094943C (cs)
AT (1) ATE144533T1 (cs)
AU (1) AU669064B2 (cs)
CA (1) CA2123261A1 (cs)
CZ (1) CZ290445B6 (cs)
DE (1) DE69400798T2 (cs)
DK (1) DK0652228T3 (cs)
ES (1) ES2094004T3 (cs)
FI (1) FI942186A7 (cs)
GR (1) GR3022253T3 (cs)
HU (1) HU219768B (cs)
IL (1) IL109602A (cs)
NO (1) NO311223B1 (cs)
NZ (1) NZ260507A (cs)
PH (1) PH30182A (cs)
PL (1) PL179984B1 (cs)
RU (1) RU2135515C1 (cs)
SG (1) SG43071A1 (cs)
SI (1) SI0652228T1 (cs)
SK (1) SK281120B6 (cs)
TW (1) TW380129B (cs)
ZA (1) ZA943266B (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1007183A3 (fr) * 1993-06-18 1995-04-18 Solvay Ureines derivees d'alpha, omega-diaminoacides et procede pour leur preparation.
WO1996025157A1 (en) * 1995-02-17 1996-08-22 Smithkline Beecham Corporation Il-8 receptor antagonists
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
EP0915651A4 (en) 1996-06-27 2001-10-24 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
WO1997049680A1 (en) * 1996-06-27 1997-12-31 Smithkline Beecham Corporation Il-8 receptor antagonists
EP0939634A4 (en) * 1996-08-15 2001-02-21 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
WO1999050238A1 (en) 1998-03-26 1999-10-07 Santen Pharmaceutical Co., Ltd. Novel urea derivatives
US7465754B1 (en) 1999-09-15 2008-12-16 Wyeth Method of potentiating chemotherapy and treating solid tumors
EP1490054A2 (en) * 2002-03-22 2004-12-29 Eisai Co., Ltd Hemiasterlin derivatives and uses thereof in the treatment of cancer
US7332158B2 (en) * 2002-05-29 2008-02-19 Demao Yang Compositions and treatments for myelosuppression by ex vivo activated immune cells
US7048922B2 (en) * 2002-05-29 2006-05-23 Demao Yang Stimulation of hematopoiesis by ex vivo activated immune cells
AR041834A1 (es) * 2002-10-29 2005-06-01 Smithkline Beecham Corp Compuesto de difenilurea sustituido con sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion
US20060057121A1 (en) * 2004-09-10 2006-03-16 Demao Yang Compositions and treatments using ex vivo activated cells for myelosuppressed patients
JP5269763B2 (ja) * 2006-04-21 2013-08-21 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Ｉｌ−８受容体アンタゴニスト
JP2009534420A (ja) * 2006-04-21 2009-09-24 スミスクライン・ビーチャム・コーポレイション Ｉｌ−８受容体アンタゴニスト
TW200817006A (en) * 2006-06-23 2008-04-16 Smithkline Beecham Corp IL-8 receptor antagonist
KR102045591B1 (ko) 2012-03-30 2019-12-02 지보당 에스아 식품 향미 화합물로서의 감마 아미노-부티르산 및 베타 알라닌의 n-아실 유도체
CA2868058C (en) 2012-03-30 2019-12-17 Givaudan S.A. N-acylated methionine derivatives as food flavouring compounds
JP6248092B2 (ja) 2012-03-30 2017-12-13 ジボダン エス エー 食品フレーバー付与化合物としてのｎ−アシル化１−アミノシクロアルキルカルボン酸
CA2868077C (en) 2012-03-30 2020-09-29 Givaudan S.A. Powder flavour composition
BR112014023959B1 (pt) 2012-03-30 2020-10-20 Givaudan Sa composição comestível
CN104219964B (zh) 2012-03-30 2016-09-21 奇华顿股份有限公司 作为食品加香化合物的n-酰基脯氨酸衍生物
US10836712B2 (en) 2012-03-30 2020-11-17 Givaudan S.A. Organic compounds
WO2013149025A1 (en) * 2012-03-30 2013-10-03 Givaudan, S., A. N-acyl serine derivatives as food flavouring compounds
WO2015050535A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
CN105636934B (zh) 2013-10-02 2019-03-29 奇华顿股份有限公司 N-酰化的2-氨基异丁酸化合物和包含它们的香味组合物
US20160227825A1 (en) 2013-10-02 2016-08-11 Givaudan Sa Organic Compounds having Taste-Modifying Properties
WO2015050534A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
CN105592719B (zh) 2013-10-02 2020-03-10 奇华顿股份有限公司 有机化合物
GB201317424D0 (en) 2013-10-02 2013-11-13 Givaudan Sa Improvements in or relating to organic compounds
CN105658089B (zh) 2013-10-02 2019-07-09 奇华顿股份有限公司 有机化合物
US10834943B2 (en) 2013-10-02 2020-11-17 Givaudan S.A. Organic compounds having taste-modifying properties
EP3672939A1 (en) 2017-08-21 2020-07-01 Celgene Corporation Processes for preparation of (s)-tert-butyl 4,5-diamino-5-oxopentanoate
CN109601739B (zh) * 2019-01-17 2022-10-14 河南湾流生物科技有限公司 一种复合氨基酸饲料添加剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
US4725582A (en) * 1978-11-14 1988-02-16 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
US4349466A (en) * 1978-11-14 1982-09-14 Fujisawa Pharmaceutical Co Peptide, process for preparation thereof and use thereof
FR2460290A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent
ES8604609A1 (es) * 1985-07-02 1986-02-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 1-(n-(1(r,s)-(etoxi- carbonil)-3-fenilpropil)-l-alanil)-l-prolina
ATE174794T1 (de) * 1991-09-27 1999-01-15 Univ Texas Parenteral anzuwendende aminosäuren enthaltende zubereitungen zur bekämpfung von hypotension und verwandten pathologien

Also Published As

Publication number Publication date
FI942186L (fi) 1994-11-13
FI942186A0 (fi) 1994-05-11
DE69400798T2 (de) 1997-03-13
HU9401444D0 (en) 1994-08-29
SK49194A3 (en) 1995-02-08
NO941786D0 (no) 1994-05-11
JP3583469B2 (ja) 2004-11-04
CZ290445B6 (cs) 2002-07-17
SK281120B6 (sk) 2000-12-11
US5616612A (en) 1997-04-01
US5312831A (en) 1994-05-17
GR3022253T3 (en) 1997-04-30
EP0652228A1 (en) 1995-05-10
CZ98194A3 (en) 1994-12-15
PL179984B1 (pl) 2000-11-30
US5602275A (en) 1997-02-11
US5633280A (en) 1997-05-27
CA2123261A1 (en) 1994-11-13
ATE144533T1 (de) 1996-11-15
AU6304394A (en) 1994-11-17
CN1100413A (zh) 1995-03-22
NO941786L (no) 1994-11-14
DK0652228T3 (da) 1996-11-25
US5545662A (en) 1996-08-13
IL109602A0 (en) 1994-08-26
JPH07179414A (ja) 1995-07-18
FI942186A7 (fi) 1994-11-13
TW380129B (en) 2000-01-21
NZ260507A (en) 1996-02-27
PH30182A (en) 1997-01-21
RU2135515C1 (ru) 1999-08-27
NO311223B1 (no) 2001-10-29
ES2094004T3 (es) 1997-01-01
SG43071A1 (en) 1997-10-17
US5658945A (en) 1997-08-19
SI0652228T1 (en) 1997-10-31
HU219768B (hu) 2001-07-30
HUT67038A (en) 1995-01-30
ZA943266B (en) 1995-01-12
KR100296543B1 (ko) 2001-11-22
CN1094943C (zh) 2002-11-27
AU669064B2 (en) 1996-05-23
DE69400798D1 (de) 1996-11-28
EP0652228B1 (en) 1996-10-23

Similar Documents

Publication Publication Date Title
IL109602A (en) Urethanes and ureas that induce cytokine production process for their preparation and pharmaceutical compositions containing them
RU94016389A (ru) Карбаматы и карбамиды, индуцирующие производство цитокинов
IL150223A (en) Lipopeptides and pharmaceuticals containing them
PL293795A1 (en) Method of obtaining cyclic urea derivatives
TW200504069A (en) Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors
DK0625989T3 (da) DNA-sekvenser kodende for hidtil ukendte vækst-/differentieringsfaktorer
DE69522947D1 (en) Phenylxanthin-derivate
IL113160A (en) Lipopeptide a1437 derivatives a process for their preparation and pharmaceutical compositions containing them
IL196900A (en) Autologous T cell vaccine compositions
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU8163294A (en) Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
BR0002577A (pt) Suspensões orais de trovafloxacina
IL113178A (en) 8alpha-3-hydroxyestra-1,3,5(11)tetraen-17-one( 9(11)-dehydro-8-isoestrone) its preparation and pharmaceutical composition containing it
ATE213233T1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
ES8301244A1 (es) Procedimiento para la obtencion de derivados de sisomicina.
ES8301274A1 (es) Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
DE3260276D1 (en) Peptide antibiotic, component a, process for its preparation and its use in medicines
IL87197A0 (en) Leukotriene antagonists,precursors of same,processes for the preparation thereof and pharmaceutical compositions containing same
GR3015706T3 (en) Benzylselenobenzamides of aminopyridines and picolylamines.
MY103900A (en) 6-substituted 2'', 3''-dideoxynucleosides and pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees